We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DIFF:BCHAINBitcoin Difficulty Analysis

Data as of 2026-05-22 - not real-time

₹320.35

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Diffusion Engineers’ stock is trading at around ₹320, comfortably above its 20‑day (≈₹311) and 200‑day (≈₹316) simple moving averages, signaling a short‑term bullish bias. The MACD line sits just above its signal line, producing a modest positive histogram that reinforces the upward momentum. RSI at roughly 59 suggests the shares are not yet overbought, leaving room for further upside. Volume has been picking up, supporting the price advance. However, the 30‑day volatility exceeds 34%, indicating price swings can be sharp.
On the fundamentals side, revenue surged 41% year‑over‑year and margins remain healthy, with a gross margin near 35% and operating margin around 15%. The trailing PE of about 25 is well below the industry average of 29, implying relative cheapness on a earnings basis. Yet a discounted cash‑flow model caps fair value near ₹171, far lower than the current price, flagging potential overvaluation. The company carries a high debt‑to‑equity ratio of over 7, but its cash pile of roughly ₹976 million exceeds debt, mitigating balance‑sheet stress. Dividend yield is modest at 0.47% with a payout ratio under 12%, making the payout sustainable. The stock’s beta of 0.73 points to lower systematic risk, while the low average daily volume raises liquidity concerns. Given the mix of strong growth, modest valuation discounts, and elevated leverage, the outlook leans toward a cautious hold.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day, 50‑day and 200‑day SMAs
  • Bullish MACD with positive histogram
  • High short‑term volatility and proximity to resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 41% and solid operating margins
  • Trailing PE below industry average
  • Net cash position exceeds total debt

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF fair value far below current price
  • Elevated debt‑to‑equity ratio
  • Sustainable dividend with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth41.00%
Profit Margin11.94%
P/E Ratio25.3
ROE13.01%
ROA8.55%
Debt/Equity7.06
P/B Ratio2.9
Op. Cash Flow₹227.9M
Free Cash Flow₹-233416256
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI59.2
Support₹290.00
Resistance₹336.50
MA 20₹311.12
MA 50₹288.00
MA 200₹316.45
MACDBullish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value₹171.41
GradeFair
TypeBlend
Dividend Yield0.47%

Risk Assessment

Beta0.74
Volatility34.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.